FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:1820-1822 October 28, 2004 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Should the public registration of clinical trials be voluntary or mandatory, as bills introduced earlier this month in Congress would require? What trials should be included? Proposals for mandatory registration have gained support because of concerns about the effects on medical practice of concealing negative data, concerns about the protection of research subjects, particularly in studies of investigational products, and concerns about the availability of information to researchers, physicians, people seeking to enroll as subjects in trials, and the public.^1,2 Critics argue that mandatory registration could reveal information that manufacturers consider proprietary, such as the results of small or exploratory . . . [Full Text of this Article]

This article has been cited by other articles:

• Lott, J. P., Drazen, J. M. (2007). Trial Registration. NEJM 356: 1581-1581 [Full Text]  
• Santoro, E., Rossi, V., Pandolfini, C., Bonati, M. (2006). DEC-net: the development of the European register of clinical trials on medicines for children. Clin Trials 3: 366-375 [Abstract]  
• Popp, R. L., Lorell, B. H., Stone, G. W., Laskey, W., Smith, J. J., Kaplan, A. V. (2006). An Outline for Public Registration of Clinical Trials Evaluating Medical Devices. J Am Coll Cardiol 47: 1518-1521 [Abstract] [Full Text]  
• Zarin, D. A., Tse, T., Ide, N. C. (2005). Trial Registration at ClinicalTrials.gov between May and October 2005. NEJM 353: 2779-2787 [Abstract] [Full Text]  
• Hayward, R. A., Kent, D. M., Vijan, S., Hofer, T. P. (2005). Reporting Clinical Trial Results To Inform Providers, Payers, And Consumers. Health Aff (Millwood) 24: 1571-1581 [Abstract] [Full Text]  
• Norris, J. W. (2005). Antiplatelet Agents in Secondary Prevention of Stroke: A Perspective. Stroke 36: 2034-2036 [Abstract] [Full Text]  
• Abraham, E. (2005). The AJRCCM in 2005. Am. J. Respir. Crit. Care Med. 171: 1-2 [Full Text]